BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 11216533)

  • 21. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P; Knight LC; Welch MJ
    Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.
    Chen X; Park R; Tohme M; Shahinian AH; Bading JR; Conti PS
    Bioconjug Chem; 2004; 15(1):41-9. PubMed ID: 14733582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.
    Yang J; Guo H; Gallazzi F; Berwick M; Padilla RS; Miao Y
    Bioconjug Chem; 2009 Aug; 20(8):1634-42. PubMed ID: 19552406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
    Dijkgraaf I; Kruijtzer JA; Frielink C; Soede AC; Hilbers HW; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC
    Nucl Med Biol; 2006 Nov; 33(8):953-61. PubMed ID: 17127167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
    Sancey L; Ardisson V; Riou LM; Ahmadi M; Marti-Batlle D; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2037-47. PubMed ID: 17674000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [(131)I labeling and bioactivity evaluation of a novel RGD dimer targeted to integrin αvβ3 receptor].
    Zhang CL; Wang RF; Zhang L; Guo FQ; Li L; Kang L; Yan P; Yang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):295-300. PubMed ID: 21503130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
    Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
    Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
    Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
    J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
    Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
    Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of glycosylated octreotate analogues labeled with radioiodine and 211At via a tin precursor.
    Vaidyanathan G; Affleck DJ; Schottelius M; Wester H; Friedman HS; Zalutsky MR
    Bioconjug Chem; 2006; 17(1):195-203. PubMed ID: 16417269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides.
    Yang J; Lu J; Miao Y
    Mol Pharm; 2012 May; 9(5):1418-24. PubMed ID: 22452443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
    Zhang X; Chen X
    Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model.
    Ahmadi M; Sancey L; Briat A; Riou L; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
    Cancer Biother Radiopharm; 2008 Dec; 23(6):691-700. PubMed ID: 19111043
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.